4//SEC Filing
Kilroy Conor 4
Accession 0001209191-20-028895
CIK 0001446847other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 5:19 PM ET
Size
6.7 KB
Accession
0001209191-20-028895
Insider Transaction Report
Form 4
Kilroy Conor
SVP, GC & Secretary
Transactions
- Sale
Class A Common Stock
2020-05-11$10.35/sh−158$1,635→ 129,479 total - Sale
Class A Common Stock
2020-05-11$10.35/sh−558$5,775→ 128,921 total
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on August 1, 2016.
- [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on May 1, 2019.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001808510
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 5:19 PM ET
- Size
- 6.7 KB